{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:44:41Z","timestamp":1760150681950,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jpainsymman.2024.01.026","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T12:48:29Z","timestamp":1706014109000},"page":"e487-e492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Should Cannabis be Used for Anorexia in Patients With Cancer?"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7903-3993","authenticated-orcid":false,"given":"Mellar","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Cyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7347-8855","authenticated-orcid":false,"given":"Gregory B.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0640-0171","authenticated-orcid":false,"given":"Amy A.","family":"Case","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0001","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/pharmrev.122.000600","article-title":"Goods and bads of the endocannabinoid system as a therapeutic target: lessons learned after 30 years","volume":"75","author":"Maccarrone","year":"2023","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0002","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/COC.0000000000000718","article-title":"Medical cannabis in cancer patients: a survey of a community hematology oncology population","volume":"43","author":"Macari","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0003","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1200\/JCO.2005.01.8010","article-title":"Systematic review of the treatment of cancer-associated anorexia and weight loss","volume":"23","author":"Yavuzsen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0004","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1200\/JCO.2004.03.103","article-title":"Appetite and cancer-associated anorexia: a review","volume":"22","author":"Davis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0005","first-page":"693","article-title":"Early satiety in cancer patients: a common and important but underrecognized symptom","volume":"14","author":"Davis","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.43848","article-title":"Placebo response and media attention in randomized clinical trials assessing cannabis-based therapies for pain: a systematic review and meta-analysis","volume":"5","author":"Gedin","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0007","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0008","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2019","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0009","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0010","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.22.01632","article-title":"Phase IIb randomized, placebo-controlled, dose-escalating, double-blind study of cannabidiol oil for the relief of symptoms in advanced cancer (MedCan1-CBD)","volume":"41","author":"Hardy","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0011","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/can.2021.0048","article-title":"The effect of cannabis-based medicine in the treatment of cachexia: a systematic review and meta-analysis","volume":"6","author":"Hammond","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0012","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/02692163221083437","article-title":"Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: a systematic review","volume":"36","author":"Razmovski-Naumovski","year":"2022","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/nu15133014","article-title":"Prevention of taste alterations in patients with cancer receiving paclitaxel- or oxaliplatin-based chemotherapy: a Pilot trial of cannabidiol","volume":"15","author":"Dominiak","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0014","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/annonc\/mdq727","article-title":"Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial","volume":"22","author":"Brisbois","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0015","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.22.01997","article-title":"Randomized double-blind placebo-controlled study of olanzapine for chemotherapy-related anorexia in patients with locally advanced or metastatic gastric, hepatopancreaticobiliary, and lung cancer","volume":"41","author":"Sandhya","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0016","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2147\/CMAR.S191330","article-title":"Low-dose of olanzapine has ameliorating effects on cancer-related anorexia","volume":"11","author":"Okamoto","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0017","first-page":"951","article-title":"Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial","volume":"18","author":"Navari","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0018","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2007-1004592","article-title":"Effects of olanzapine on slow wave sleep, sleep spindles and sleep-related memory consolidation in schizophrenia","volume":"41","author":"Goder","year":"2008","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0019","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00213-006-0633-7","article-title":"Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers","volume":"190","author":"Gimenez","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4088\/JCP.v66n0407","article-title":"Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients","volume":"66","author":"Sharpley","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092447","article-title":"Cannabis consumption used by cancer patients during Immunotherapy correlates with poor clinical outcome","volume":"12","author":"Bar-Sela","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0022","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0023","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1111\/bph.13892","article-title":"Cannabinoid CB(1) \/CB(2) receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia","volume":"174","author":"Scherma","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0024","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bmcl.2009.11.117","article-title":"Synthesis and evaluation of 3-amino-6-aryl-pyridazines as selective CB(2) agonists for the treatment of inflammatory pain","volume":"20","author":"Gleave","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41398-020-0756-3","article-title":"Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study","volume":"10","author":"Farokhnia","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0026","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1196\/annals.1432.035","article-title":"Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption","volume":"1139","author":"Onaivi","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0027","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/02692163221083437","article-title":"Efficacy of medicinal cannabis for appetite-related symptoms in people with cancer: a systematic review","volume":"36","author":"Razmovski-Naumovski","year":"2022","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0028","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.3390\/ijms23147929","article-title":"The origin and biomedical relevance of cannabigerol","volume":"23","author":"Jastrz\u0105b","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0029","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s00213-016-4397-4","article-title":"Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats","volume":"233","author":"Brierley","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0030","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/jpet.120.000340","article-title":"The pharmacological case for cannabigerol","volume":"376","author":"Nachnani","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0031","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/1060028020930189","article-title":"Clinical data for the use of cannabis-based treatments: a comprehensive review of the literature","volume":"54","author":"Inglet","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108680","article-title":"Approved cannabinoids for medical purposes: comparative systematic review and meta-analysis for sleep and appetite","volume":"196","author":"Spanagel","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0033","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40261-022-01205-y","article-title":"Effects of cannabidiol on appetite and body weight: a systematic review","volume":"42","author":"Pinto","year":"2022","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0034","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ejp.1605","article-title":"The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: a randomized, double-blinded, placebo-controlled trial","volume":"24","author":"Almog","year":"2020","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0035","first-page":"3336516","article-title":"Pharmacological aspects and biological effects of cannabigerol and its synthetic derivatives","volume":"2022","author":"Mondello","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0036","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1\u2013CB2 heteroreceptor complexes","volume":"9","author":"Navarro","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0037","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1634\/theoncologist.2018-0383","article-title":"Cannabis impacts tumor response rate to nivolumab in patients with advanced malignancies","volume":"24","author":"Taha","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0038","unstructured":"Americans for Safe Access. Available at: www.safeaccessnow.org. Accessed October 22, 2023."},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0039","first-page":"39","article-title":"Multinational Association of Supportive Care in Cancer (MASCC) expert opinion\/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer","volume":"31","author":"Alderman","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcsm.12861","article-title":"Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta-analysis","volume":"13","author":"Simon","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jpainsymman.2024.01.026_bib0041","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/pds.4999","article-title":"Translational hurdles with cannabis medicines","volume":"10","author":"Graham","year":"2020","journal-title":"Pharmacoepidemiology Drug Saf"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392424000459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392424000459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:40:03Z","timestamp":1760132403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392424000459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0885392424000459"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2024.01.026","relation":{},"ISSN":["0885-3924"],"issn-type":[{"type":"print","value":"0885-3924"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should Cannabis be Used for Anorexia in Patients With Cancer?","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2024.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}